Younger vs older donors for stem cell transplant
Part of Blood & lymphatic clinical trials.
This study compares stem cell transplants from younger vs. older donors for people with blood cancers. Researchers want to see which donor age group leads to better outcomes after your first transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer (like leukemia, lymphoma, or multiple myeloma).
- This is your first stem cell transplant from a donor.
- Your donor's tissue type matches yours at least 50% (HLA match of 0.5 or higher).
- Your doctor can tell us your donor's age and your follow-up information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special health evaluation designed for older adults can help doctors better plan stem cell transplants for people 55 and older with blood disorders. You would receive a series of questionnaires and tests to assess your overall health before transplant.
This trial compares using a cousin or a sibling as a stem cell donor for people with blood cancers who need a half-matched (haploidentical) transplant. It looks at how well the transplant works and how patients recover.
This study compares a newer type of stem cell transplant (using special cells) to the standard method for children who need a half-matched donor. It aims to see if the new approach is safer and works as well.
This trial studies a special donor stem cell transplant where the donor’s immune cells are reduced, aiming to lower harmful immune attacks after transplant. It may help children and young adults with certain high-risk blood cancers or rare bone marrow disorders.
This study looks at what factors might affect whether people who need a donor stem cell transplant actually get one. It aims to help make sure everyone has a fair chance to receive this treatment.
This study looks at using a “half-matched” stem cell transplant (haploidentical transplant) in adults around your age with acute leukemia or MDS. It may help people who cannot find a fully matched donor, but are still eligible for this type of transplant.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.